Elisabetta Trifirò

402 total citations
9 papers, 307 citations indexed

About

Elisabetta Trifirò is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Elisabetta Trifirò has authored 9 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Cardiology and Cardiovascular Medicine and 2 papers in Surgery. Recurrent topics in Elisabetta Trifirò's work include Inflammatory mediators and NSAID effects (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Elisabetta Trifirò is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Elisabetta Trifirò collaborates with scholars based in Italy and United States. Elisabetta Trifirò's co-authors include Fabio M. Pulcinelli, Livia Di Renzo, Silvia Riondino, Gloria Saccani Jotti, Paola Gazzaniga, Luigi Frati, Lavinia Vittoria Lotti, Luigi M. Biasucci, Andrea Celestini and Pasquale Pignatelli and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Elisabetta Trifirò

9 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabetta Trifirò Italy 8 141 101 56 47 46 9 307
Sue Fox United Kingdom 14 283 2.0× 103 1.0× 148 2.6× 70 1.5× 15 0.3× 21 490
M Cucuianu Romania 11 56 0.4× 132 1.3× 83 1.5× 76 1.6× 10 0.2× 69 423
Lynn Crosbie United Kingdom 12 75 0.5× 61 0.6× 47 0.8× 90 1.9× 9 0.2× 15 414
Aaruni Saxena India 7 75 0.5× 67 0.7× 17 0.3× 42 0.9× 13 0.3× 10 291
Adriana Yamaguchi United States 11 42 0.3× 32 0.3× 20 0.4× 41 0.9× 9 0.2× 23 322
Gryglewski Rj Poland 9 67 0.5× 70 0.7× 12 0.2× 42 0.9× 6 0.1× 40 307
L. Lerond France 11 53 0.4× 36 0.4× 12 0.2× 164 3.5× 18 0.4× 15 372
Mohsen Firoozrai Iran 14 121 0.9× 37 0.4× 33 0.6× 69 1.5× 14 0.3× 42 424
R. Morazain Canada 11 63 0.4× 35 0.3× 24 0.4× 109 2.3× 16 0.3× 17 375
Cody J. Freedman United States 7 41 0.3× 36 0.4× 22 0.4× 21 0.4× 5 0.1× 7 203

Countries citing papers authored by Elisabetta Trifirò

Since Specialization
Citations

This map shows the geographic impact of Elisabetta Trifirò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Trifirò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Trifirò more than expected).

Fields of papers citing papers by Elisabetta Trifirò

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Trifirò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Trifirò. The network helps show where Elisabetta Trifirò may publish in the future.

Co-authorship network of co-authors of Elisabetta Trifirò

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Trifirò. A scholar is included among the top collaborators of Elisabetta Trifirò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Trifirò. Elisabetta Trifirò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Trifirò, Elisabetta, et al.. (2013). Cyclooxygenase-2 is induced by p38 MAPK and promotes cell survival. Oncology Reports. 29(5). 1999–2004. 10 indexed citations
2.
Pulcinelli, Fabio M., Elisabetta Trifirò, Isabella Massimi, & Livia Di Renzo. (2012). A functional interaction between TRPC/NCKX induced by DAG plays a role in determining calcium influx independently from PKC activation. Platelets. 24(7). 554–559. 7 indexed citations
3.
Guerriero, Raffaella, Lavinia Vittoria Lotti, Elisabetta Trifirò, et al.. (2011). Aspirin Extrusion From Human Platelets Through Multidrug Resistance Protein-4–Mediated Transport. Journal of the American College of Cardiology. 58(7). 752–761. 66 indexed citations
4.
Trifirò, Elisabetta, et al.. (2009). Effects of Pomegranate Juice and Extract Polyphenols on Platelet Function. Journal of Medicinal Food. 12(2). 334–339. 48 indexed citations
5.
Pulcinelli, Fabio M., Luigi M. Biasucci, Silvia Riondino, et al.. (2009). COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment. European Heart Journal. 30(10). 1279–1286. 62 indexed citations
6.
Trifirò, Elisabetta, Shirley Williams, Yann Chéli, et al.. (2009). The low-frequency isoform of platelet glycoprotein VIb attenuates ligand-mediated signal transduction but not receptor expression or ligand binding. Blood. 114(9). 1893–1899. 26 indexed citations
7.
Gradilone, Angela, Fabio M. Pulcinelli, Lavinia Vittoria Lotti, et al.. (2008). Celecoxib Upregulates Multidrug Resistance Proteins in Colon Cancer: Lack of Synergy with Standard Chemotherapy. Current Cancer Drug Targets. 8(5). 414–420. 23 indexed citations
8.
Riondino, Silvia, Elisabetta Trifirò, Livia Di Renzo, et al.. (2008). Lack of biological relevance of platelet cyclooxygenase-2 dependent thromboxane A2 production. Thrombosis Research. 122(3). 359–365. 13 indexed citations
9.
Pulcinelli, Fabio M., Silvia Riondino, Andrea Celestini, et al.. (2005). Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin. Journal of Thrombosis and Haemostasis. 3(12). 2784–2789. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sue Fox Breakdown of academic impact, for papers by M Cucuianu Breakdown of academic impact, for papers by Lynn Crosbie Breakdown of academic impact, for papers by Aaruni Saxena Breakdown of academic impact, for papers by Adriana Yamaguchi Breakdown of academic impact, for papers by Gryglewski Rj Breakdown of academic impact, for papers by L. Lerond Breakdown of academic impact, for papers by Mohsen Firoozrai Breakdown of academic impact, for papers by R. Morazain Breakdown of academic impact, for papers by Cody J. Freedman
Rankless by CCL
2026